NITTO DENKO CORPORATION FY2027 Q1 Earnings Report

Quick View

Executive Summary

FY2027 Q1 recorded increases in both revenue and profit, with profit growth outpacing revenue growth due to the realization of operating leverage. Revenue was ¥2716.7B (+10.3% YoY), Operating Income was ¥492.1B (+15.4%), and Net Income attributable to owners of the parent was ¥338.7B (+8.2%). The primary drivers of profit growth were a significant increase in profit from Industrial Tapes and a reduction in losses in Human Life. Meanwhile, the core Optoronics segment posted lower profit despite maintaining a high profit margin.

Factors Affecting Performance

【Revenue】Revenue was ¥2716.7B, up +10.3% YoY. By segment, Optoronics generated ¥1314.8B (48.4% of total, YoY +1.3%), Industrial Tapes generated ¥1006.9B (37.1%, YoY +18.2%), and Human Life generated ¥392.4B (14.4%, YoY +27.0%). While the largest segment, Optoronics, showed limited growth, Tapes and Human Life drove the increase in revenue.

【Profit and Loss】Operating Income was ¥492.1B (+15.4% YoY), and the Operating Margin of 18.1% increased by +0.8pt from the same period of the previous year. The Gross Margin of 37.6% was largely unchanged, while the SG&A ratio declined to 14.5% from 15.1%, driving the improvement in profitability. Segment profit at Industrial Tapes recovered sharply to ¥162.8B (+64.9%, 16.2% margin), while the loss at Human Life narrowed to ¥3.2B from a loss of ¥16.3B in the previous year. In contrast, Optoronics reported ¥353.8B (-3.8%, 26.9% margin), representing a decline in profit. Profit Before Tax was ¥495.8B (+14.5%), but the increase in Net Income slowed to +8.2% due to a higher effective tax rate (income taxes of ¥156.9B). Overall, the company recorded increases in both revenue and profit, with the quality of profit growth dependent on improvement in Tapes and Human Life.

Segment Analysis

Optoronics is the largest source of profit, with Operating Income of ¥353.8B accounting for approximately 72% of consolidated Operating Income, but its growth has slowed, with revenue up +1.3% and profit down -3.8%. Industrial Tapes achieved profit growth of +64.9%, exceeding its revenue growth of +18.2%, while its margin improved from approximately 11.6% to 16.2%. Human Life expanded with revenue growth of +27.0%, while reducing its operating loss from ¥16.3B to ¥3.2B and approaching profitability. A notable feature is that the driver of profit growth has shifted from the core business to non-core businesses.

Key Financial Indicators

【Profitability】The Operating Margin was 18.1% (17.3% in the previous year), while the Net Profit Margin of 12.5% also improved year on year. The decline in the SG&A ratio contributed to the improvement while the Gross Margin of 37.6% was maintained.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥231.9B, and its ratio to Net Income of ¥338.7B remained at 0.68x. An increase in working capital, including a ¥159.8B increase in trade receivables and a ¥31.6B increase in inventories, constrained cash conversion.【Investment Efficiency】ROE was 3.0% (on a quarterly basis; the annualized level is estimated to be approximately 11-12%), while capital expenditures of ¥281.2B represented 10.4% of revenue, indicating continued aggressive investment.【Financial Soundness】The Equity Ratio was 79.5%, cash and cash equivalents totaled ¥2990.6B, and liabilities remained at only 20.4% of total assets, indicating an extremely strong financial foundation.

Cash Flow Analysis

Operating Cash Flow (OCF) was ¥231.9B, an increase of +25.9% YoY, but its conversion rate relative to Net Income of ¥338.7B remained at 0.68x. The primary factors were increases of ¥159.8B in trade and other receivables and ¥31.6B in inventories, which were not offset by the ¥12.9B increase in trade payables. Investing Cash Flow was -¥362.1B, of which capital expenditures accounted for ¥281.2B, representing 10.4% of revenue and indicating a high level of investment. Financing Cash Flow was -¥520.2B, with dividend payments of ¥202.1B and ¥294.9B in share repurchases and other items as the primary sources of outflows. As a result, Free Cash Flow was -¥130.2B, meaning that investment and shareholder returns were not funded solely by OCF. However, cash and cash equivalents remained ample at ¥2990.6B, limiting the short-term impact on liquidity.

Earnings Quality

The core of earnings consists of recurring operating profit, and no temporary factors equivalent to extraordinary gains or losses have been identified. Financial income of ¥10.6B exceeded financial expenses of ¥6.9B, making a modest positive contribution to non-operating income. Meanwhile, the fact that Net Income growth was limited to +8.2%, compared with +14.5% growth in Profit Before Tax, was attributable to an increase in the effective tax rate from the previous year (income taxes of ¥156.9B; effective tax rate of approximately 31.7%), rather than a slowdown in the underlying earnings power of the business. From an accruals perspective, the increase in trade receivables and inventories has widened the gap between accrual-based earnings and OCF. The OCF/Net Income ratio of 0.68x is at a level requiring monitoring in terms of earnings cash conversion. Comprehensive Income was ¥487.5B, substantially exceeding Net Income of ¥338.9B, primarily due to foreign currency translation adjustments for foreign operations of ¥147.1B; this does not represent the underlying earnings power of the business.

Earnings Forecast and Guidance

The full-year company forecast is revenue of ¥11100B, Operating Income of ¥2000B (+8.9% YoY), and Net Income of ¥1420B (+6.4%). Q1 progress rates were 24.5% for revenue, 24.6% for Operating Income, and 23.9% for Net Income, broadly in line with the simple quarterly run-rate of 25%. At present, no significant upside or downside relative to the full-year forecast is evident. Although the earnings forecast was revised during the current quarter, the dividend forecast was not revised.

Shareholder Returns

The full-year dividend forecast is ¥64.00 per share, implying a forecast Payout Ratio of approximately 30.1% based on forecast full-year EPS of ¥212.75. The previous-year dividend was ¥30 per share (based on the interim dividend), indicating a trend toward higher dividends. In addition to dividend payments of ¥202.1B during the current quarter, ¥294.9B was spent on share repurchases and other items, bringing total quarterly shareholder returns to ¥496.9B. On a dividend-only basis, the Payout Ratio is approximately 30%, a sustainable level. However, the Total Return Ratio, including share repurchases, was high at 146.7% of quarterly profit, indicating an enhanced shareholder return policy supported by retained earnings and cash balances (¥2990.6B). Free Cash Flow of -¥130.2B indicates that the funding source for shareholder returns was not dependent solely on OCF.

Risk Factors

1. Slowing growth in the core business: Optoronics is the core business, accounting for approximately 72% of consolidated Operating Income, but it has shifted to a decline in profit, with revenue up +1.3% and Operating Income down -3.8%. The company’s performance is structurally influenced by demand trends and product mix in this business, which therefore requires monitoring.

2. Declining cash conversion due to working capital growth: OCF of ¥231.9B was only 0.68x Net Income of ¥338.7B, primarily due to increases of ¥159.8B in trade receivables and ¥31.6B in inventories. If this condition persists, it may constrain funding for investment and shareholder returns.

3. Higher inventory levels: Inventories increased by +¥31.6B from the beginning of the period. In the functional materials and electronic materials fields, there are risks of impairment losses and production adjustments resulting from demand fluctuations and product-generation changes.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Margin and Net Profit Margin are substantially above the industry median, placing profitability in the upper tier of the industry.

Growth and Capital Efficiency

The revenue growth rate also exceeds the industry median, but does not reach the upper end of the industry range (14.6%), indicating that growth is less outstanding than profitability.

※Source: Compiled by the Company

Key Earnings Highlights

1. The Operating Margin of 18.1% (+0.8pt YoY) remains substantially above the industry median. A structural change was observed whereby the recovery in profitability at Industrial Tapes and the reduction in losses at Human Life became the sources of profit growth.

2. While core Optoronics shifted to a decline in profit, non-core businesses drove profit growth. The resulting diversification of profit sources is a notable feature of the earnings structure.

3. The combination of an OCF/Net Income ratio of 0.68x, higher inventories, and Free Cash Flow of -¥130.2B indicates factors requiring monitoring in terms of working capital and investment burdens despite strong performance in the income statement.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,876–¥1,987 for Cost of Equity ±1%; ¥1,925–¥1,938 for ω±0.1.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is neither a forecast of the market share price nor a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Nitto Denko delivered a strong FY2027 Q1 operating performance, with double-digit sales growth, faster operating-profit growth, and material improvement in the Human Life loss. Revenue rose 10.3% year on year to JPY271.7bn. Operating income increased 15.4% to JPY49.2bn. Profit attributable to owners increased 8.2% to JPY33.9bn, and basic EPS rose to JPY50.75 from JPY45.68. The operating margin expanded by 79bp to 18.1%, comfortably above the 15% excellent-profitability benchmark. Gross margin was effectively stable, edging up by 3bp to 37.6%, indicating that the operating-margin expansion was driven primarily by operating leverage and improved business mix rather than a broad gross-margin uplift. Net margin declined by 24bp to 12.5%, because the effective tax rate increased to 31.7% from 27.7% despite the operating improvement. Industrial Tape was the principal earnings-growth engine, with segment operating income rising 64.9% year on year to JPY16.3bn. Optoelectronics remained the core business by operating-income contribution, generating JPY35.4bn of segment profit, although its profit declined 3.8% year on year. Human Life narrowed its operating loss substantially to JPY0.3bn from JPY1.6bn, providing an important incremental earnings tailwind. The annualized ROE was 11.8%, a good level under the stated benchmark, supported mainly by a 12.5% net margin and modest 1.26x financial leverage. Cash conversion was the principal earnings-quality issue: operating cash flow of JPY23.2bn covered only 0.68x net income. The shortfall reflected working-capital absorption, notably a JPY16.0bn increase in receivables and a JPY3.2bn inventory increase, alongside JPY15.1bn of tax payments. Free cash flow was negative JPY13.0bn after JPY28.1bn of capital expenditure, but this reflects an investment phase rather than a balance-sheet funding constraint. Financial capacity remains strong, with a 79.5% equity ratio, estimated current ratio of 3.48x, and D/E of 0.26x. Q1 progress against the revised full-year forecast is broadly in line with seasonal expectations, with revenue at 24.5%, operating income at 24.6%, and net income at 23.9% of guidance. The central forward implication is that Industrial Tape momentum and Human Life loss reduction need to offset the modest profit decline in the much larger Optoelectronics profit pool, while receivables, inventories, and cash conversion warrant close monitoring.

Profitability Analysis

The annualized DuPont ROE of 11.8% decomposes into a 12.5% net profit margin, 0.753x asset turnover, and 1.26x financial leverage. Profitability rather than leverage is the dominant driver of returns: the company generates an excellent net margin while maintaining a conservatively capitalized balance sheet. The operating margin improved to 18.1% from 17.3%, a 79bp expansion, as operating income grew 15.4%, ahead of 10.3% revenue growth. Gross margin was stable at 37.6%, only 3bp higher year on year, so the main source of incremental profitability was below gross profit. R&D expense increased 16.4% to JPY13.1bn, faster than revenue growth, raising R&D intensity to 4.8% from 4.6%. This investment level is consistent with a technology-oriented materials manufacturer, but it requires continued commercialization success to preserve margin gains. Industrial Tape recorded revenue of JPY101.1bn, up 17.8%, and operating profit of JPY16.3bn, up 64.9%; its segment margin improved 4.6 percentage points to 16.1%. Optoelectronics recorded revenue of JPY132.2bn, up 1.3%, and operating profit of JPY35.4bn, down 3.8%; its segment margin declined 1.4 percentage points to 26.8%. As the largest contributor to operating income, Optoelectronics is the core business, and the modest margin compression there is the principal profitability item to monitor. Human Life revenue increased 25.6% to JPY40.8bn and its operating loss narrowed to JPY0.3bn from JPY1.6bn, improving segment margin by 4.6 percentage points to negative 0.8%. Financial income of JPY1.1bn exceeded finance costs of JPY0.7bn, producing an interest burden of 1.008x and confirming that financing costs do not constrain earnings. The tax burden was 0.683, below the 0.70 normal benchmark, explaining why net-income growth of 8.2% trailed operating-income growth. Annualized ROA is approximately 9.4%, reflecting high operating profitability but a substantial asset base, including JPY475.7bn of PPE.

Growth Assessment

Growth quality was favorable at the operating level, with sales growth broad enough to produce a 15.4% increase in operating income. Industrial Tape was the largest incremental contributor, combining high-teens sales growth with substantial margin recovery. Human Life also grew rapidly and materially reduced losses, although reaching sustained profitability remains the relevant milestone. Optoelectronics sales were essentially flat and segment profit declined, making stabilization in this core profit contributor important for sustaining group growth. The full-year forecast calls for revenue of JPY1,110.0bn, operating income of JPY200.0bn, and net income of JPY142.0bn. Q1 achievement rates are 24.5% for revenue, 24.6% for operating income, and 23.9% for net income, all within 1.1 percentage points of the standard 25% first-quarter progress rate. Consequently, the revised forecast appears consistent with the first-quarter run rate rather than requiring a material acceleration in later quarters. The full-year plan implies year-on-year growth of 8.9% in operating income and 6.4% in net income, below the Q1 operating-profit growth rate, leaving a measured planning buffer. Recurring operating earnings appear to be the primary driver of the result: other income was JPY2.4bn and other expenses were JPY2.7bn, while impairment losses were JPY0.6bn, equivalent to only 1.9% of net income. Translation-related OCI was positive JPY14.7bn, lifting comprehensive income to JPY48.8bn, but it does not represent operating earnings. Inventory days of 88 are elevated against the 60-day manufacturing benchmark, so revenue growth should be assessed alongside inventory normalization and sell-through.

Financial Health

Financial health is robust. Total equity was JPY1,148.2bn against total liabilities of JPY294.4bn, producing a 79.5% equity ratio. D/E of 0.26x is conservative and well below the 2.0x warning threshold. Current assets of JPY787.1bn versus current liabilities of JPY226.0bn imply a current ratio of 3.48x, well above the 1.0x warning level and the 1.5x healthy benchmark. Excluding inventories, the estimated quick ratio is 2.76x, indicating ample near-term liquidity even without selling inventory. Cash and cash equivalents totaled JPY299.1bn, providing substantial coverage of current liabilities. There is no short-term funding mismatch: current assets exceed current liabilities by JPY561.1bn. Non-current liabilities were limited at JPY68.4bn, including a JPY30.1bn defined-benefit liability, JPY21.5bn of other non-current financial liabilities, and JPY13.6bn of deferred tax liabilities. Right-of-use assets were JPY20.9bn and lease payments were JPY2.3bn during Q1, representing a manageable recurring fixed commitment relative to cash generation and liquidity. Goodwill was JPY64.8bn, equal to 5.6% of equity and 4.5% of assets, well below levels associated with balance-sheet dependence on acquisition values. Intangible assets were only 1.2% of total assets, also indicating limited intangible-asset concentration. Treasury stock increased in absolute carrying value from negative JPY13.8bn at FY2026 year-end to negative JPY43.3bn at Q1-end, reflecting JPY29.5bn of share repurchases. This capital action reduced owner equity despite positive profit and OCI, with parent equity modestly decreasing to JPY1,147.1bn from JPY1,148.0bn at the fiscal-year start. The buyback is readily supported by the current capital structure, but continued repurchases should be weighed against cash conversion and capital-investment needs.

Notable B/S Changes

Treasury stock: increased in absolute negative carrying value by JPY29.5bn from FY2026 year-end to negative JPY43.3bn at Q1-end, reflecting share repurchases; this reduces equity but is readily absorbable given the 79.5% equity ratio and JPY299.1bn cash balance. Cash and cash equivalents: -JPY60.7bn from FY2026 year-end to JPY299.1bn, driven by JPY28.1bn capex, JPY20.2bn dividends, and JPY29.5bn share repurchases, partly offset by operating cash flow. Trade and other receivables: +JPY20.3bn from FY2026 year-end to JPY252.2bn, indicating working-capital absorption and contributing to the 0.68x OCF/net-income ratio. Other current assets: +JPY17.0bn from FY2026 year-end to JPY45.3bn, contributing to the decline in current assets despite high liquidity. Other financial assets (current): +JPY8.2bn from FY2026 year-end to JPY27.6bn, consistent with the JPY7.9bn cash outflow for increased time deposits. PPE: +JPY8.8bn from FY2026 year-end to JPY475.7bn, consistent with elevated Q1 capital expenditure and ongoing manufacturing investment.

Cash Flow Quality

Operating cash flow was JPY23.2bn, up from JPY18.4bn in the prior-year quarter, but it trailed net income of JPY33.9bn, producing the flagged OCF/net-income ratio of 0.68x. This is below the 0.8x quality threshold and signals that reported earnings were not fully converted into operating cash in Q1. The principal root cause was working-capital absorption: receivables increased by JPY16.0bn and inventories increased by JPY3.2bn. Payables supplied only JPY1.3bn of cash, compared with JPY7.4bn in the prior-year period, further limiting cash conversion. Inventory days of 88, above the 60-day benchmark, is the second quality alert. For a manufacturing company, this level may reflect production lead times and product mix, but it also increases exposure to demand volatility, obsolescence, and cash tied up in the operating cycle. Inventories rose to JPY163.0bn from JPY157.9bn at fiscal year-end, while revenue rose 10.3% year on year; inventory efficiency should therefore be assessed closely through subsequent quarters. The 0.7% accruals ratio remains low and is supportive of underlying earnings quality, tempering the concern from quarterly cash conversion. Capital expenditure was JPY28.1bn, equivalent to 10.4% of Q1 revenue, above the typical 3-8% manufacturing range and consistent with a meaningful investment program. Free cash flow was negative JPY13.0bn after capex. Operating cash flow did not cover Q1 capex or the JPY20.2bn dividend payment, but the liquidity position and low leverage provide ample financing capacity. Investing cash outflow also included JPY7.9bn of increased time deposits. Cash declined JPY60.7bn before the positive JPY4.3bn foreign-exchange translation effect, principally due to capex, dividends, and JPY29.5bn of buybacks. The priority is for receivable collection and inventory turnover to improve sufficiently for operating cash flow to fund recurring capex and shareholder distributions over a full-year cycle.

Dividend Sustainability

The full-year dividend forecast is JPY64 per share against forecast EPS of JPY212.75, implying a forecast dividend payout ratio of 30.1%. This is comfortably below the 60% sustainability benchmark and indicates substantial accounting-profit coverage. Q1 cash dividends paid were JPY20.2bn, equivalent to approximately 59.7% of Q1 net income, although quarterly payment timing is not directly comparable with a full-year payout policy. Dividends alone were below Q1 operating cash flow of JPY23.2bn. However, dividends plus JPY29.5bn of share repurchases totaled JPY49.7bn, equivalent to a Q1 cash total return ratio of approximately 146.7% of net income. This period cash total return exceeded operating cash flow and free cash flow, so it was funded in part from the substantial existing cash balance. With JPY299.1bn of cash, a 79.5% equity ratio, and D/E of 0.26x, the current shareholder-return program does not create near-term solvency pressure. Sustainability over time depends on restoring operating-cash conversion, particularly through receivables and inventory discipline, while maintaining the elevated capex program. The unchanged dividend policy alongside a revised earnings forecast supports near-term payout visibility.

Risk Assessment

Business risks include Optoelectronics, the core profit contributor, posted a 3.8% year-on-year decline in segment operating income and a 1.4 percentage-point margin decline to 26.8%; continued weakness would have an outsized effect on consolidated earnings., Industrial Tape delivered strong growth, but its sharp 64.9% profit increase creates a higher comparison base and leaves earnings sensitive to demand conditions in automotive, electronics, and industrial-materials markets., Human Life remains loss-making despite substantial improvement; execution risk remains around converting 25.6% sales growth into sustainably positive operating profit., Manufacturing demand is exposed to customer inventory adjustments, semiconductor and electronics cycles, raw-material and energy-cost movements, product-quality events, and supply-chain disruption., Positive JPY14.7bn foreign-currency translation OCI indicates material overseas exposure; exchange-rate movements can affect reported equity and potentially competitiveness and demand..

Financial risks include The OCF/net-income ratio of 0.68x is below the 0.8x threshold. Receivables increased JPY16.0bn and inventories increased JPY3.2bn, tying cash up in working capital., Inventory days of 88 exceed the 60-day benchmark. This can indicate longer production cycles, but also raises working-capital, obsolescence, and demand-mismatch risk., Free cash flow was negative JPY13.0bn, while dividends and buybacks totaled JPY49.7bn during Q1. The program is currently affordable from cash reserves, but persistent negative free cash flow would reduce flexibility., The effective tax rate rose to 31.7%, causing net-income growth to lag operating-income growth; sustained elevated taxation would limit earnings conversion..

Key concerns include Highest priority: conversion of operating profit into cash, particularly receivable collection and inventory normalization., High priority: restoring profit growth in Optoelectronics while preserving its still-high 26.8% segment margin., Moderate priority: validating that elevated capex of JPY28.1bn in Q1 produces capacity, productivity, or strategic returns sufficient to support future free cash flow., Moderate priority: monitoring the scale of buybacks relative to free cash flow, even though leverage and liquidity remain conservative..

Investment Implications

Key takeaways include Operating performance was strong: revenue increased 10.3%, operating income increased 15.4%, and the operating margin expanded 79bp to 18.1%., Industrial Tape was the leading growth driver, while Human Life's sharply reduced loss added to group earnings momentum., Optoelectronics remains the core business by operating-income contribution, but its declining sales growth and margin require attention., The balance sheet is a material strength, with a 79.5% equity ratio, 3.48x current ratio, 0.26x D/E, and JPY299.1bn of cash., Cash conversion and elevated inventory days are the main constraints on an otherwise high-quality earnings profile., The revised full-year forecast is broadly supported by Q1 progress, with all key profit-and-loss measures near the normal 25% first-quarter achievement rate..

Metrics to watch include Optoelectronics revenue growth and segment operating margin, Industrial Tape segment margin durability after the Q1 expansion to 16.1%, Human Life progress from a negative 0.8% segment margin toward sustained profitability, OCF/net-income ratio, with improvement above 0.8x as the near-term threshold, Receivables growth, inventory balance, and inventory days relative to the 88-day current level, Capital expenditure intensity and the timing of free-cash-flow normalization, Dividend-plus-buyback total return relative to annual operating cash flow and free cash flow, Foreign-exchange translation movements and their implications for overseas operations.

Regarding relative positioning, Nitto Denko combines excellent operating profitability, including an 18.1% operating margin and 12.5% net margin, with an unusually strong balance sheet for a global materials manufacturer. Its annualized ROE of 11.8% is good but remains below the >15% excellent benchmark, principally because the company operates with low financial leverage. Low goodwill exposure—5.6% of equity—and limited intangible concentration reduce acquisition-related impairment risk. Relative performance will depend on whether the company can preserve Industrial Tape momentum, arrest Optoelectronics margin pressure, and convert earnings into cash without compromising technology investment.